Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mobile-health Network Solutions Class A Ordinary Shares (MNDR)
Singapore, SG
Mobile-health Network Solutions (MNDR) functions as an investment holding company focused on delivering telehealth services across Singapore. Its business operations are primarily divided into two main segments: Telemedicine and Ancillary Services, and the sale of pharmaceutical products and medical devices. A cornerstone of its offerings is the MaNaDr platform, designed as a comprehensive digital healthcare ecosystem. This platform seamlessly connects patients with healthcare providers, offering a wide array of services and products that are conveniently accessible via both a mobile application and a dedicated website. Beyond its digital platform, MNDR delivers extensive primary care services. These encompass routine medical consultations, the diagnosis and management of both acute and chronic illnesses in adult and pediatric patients, immunizations, and various health screenings (e.g., for work permits and pre-employment checks). Additionally, the company provides specialized care for children and the elderly, alongside performing minor surgical procedures. Further diversifying its revenue streams, the company maintains an online e-commerce platform for health and wellness products. It also engages in the wholesale supply of pharmaceuticals to clinics. A key corporate offering is MaNaCare, a specialized platform delivering a suite of corporate healthcare and wellness solutions. These include access to general practitioners, specialists, and allied healthcare professionals; remote consultations; physical clinic visits; on-site health assessments; and an online community forum and marketplace, complemented by various wellness programs tailored for businesses. MNDR is also involved in the development of IT systems for mobile and web-based applications. Its physical presence includes operating pharmacies, medical clinics, and drug stores. The company extends its services to include beauty and personal care, alongside a broader spectrum of general medical and health offerings. Established in 2009, Mobile-health Network Solutions is headquartered in Singapore.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.79% | -6.25% | -5.67% | -16.33% | -70.64% | -12.86% | -88.80% | -99.71% | -99.71% | -99.71% | -99.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-58.7% Q4'25: -53.9% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+35.8% ★ Q4'25: +11.1% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-67.9% Q4'25: -109.0% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%-44.3% Q4'25: -22.2% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%-171.8% Q4'25: -70.4% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%-74.5% ★ Q4'25: +156.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-0.10× Q4'25: -0.04× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
13.97M
est: 14.28M (-2.2%)
|
5.77M
est: 25.87M (-77.7%)
|
45.65M
45.65M – 45.65M
+76.5% YoY
|
| EBITDA |
-15.55M
est: -5.74M (-171.1%)
|
-2.42M
est: -10.40M (+76.7%)
|
-18.34M
-18.34M – -18.34M
-76.5% YoY
|
| EBIT |
-15.70M
est: -5.91M (-165.7%)
|
-2.55M
est: -10.71M (+76.1%)
|
-18.89M
-18.89M – -18.89M
-76.5% YoY
|
| Net Income |
-15.60M
est: -23.0K (-67,649.9%)
|
-2.55M
est: -283.5K (-801.0%)
|
141.7K
141.7K – 141.7K
+150.0% YoY
|
| SGA |
18.09M
est: 5.79M (+212.2%)
|
2.01M
est: 10.50M (-80.8%)
|
18.52M
18.52M – 18.52M
+76.5% YoY
|
| EPS |
-22.45
est: -0.13 (-17,169.2%)
|
-14.42
est: -1.60 (-801.3%)
|
0.80
0.80 – 0.80
+150.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VIRTU FINANCIAL LLC | 26.3K +14.4K (+120.2%) | 24.0K +13.0K (+118.2%) | 1.57% +0.855 pp | 0.00% +0.001 pp | USD0.90 +0.0% | 2 qtrs — |
| 2 | UBS GROUP AG | 7.9K +5.5K (+233.4%) | 7.1K +5.0K (+236.1%) | 0.47% +0.330 pp | 0.00% +0.000 pp | USD1.91 -52.9% | 3 qtrs — |
| 3 | SBI SECURITIES CO., LTD. | 41.00 +— (+0.0%) | 37.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.24 -78.8% | 3 qtrs — |
| 4 | HRT FINANCIAL LP | — -31.5K (-100.0%) | — -28.0K (-100.0%) | 0.00% -1.872 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 5 | JANE STREET GROUP, LLC | — -12.9K (-100.0%) | — -11.5K (-100.0%) | 0.00% -0.766 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | Leong Aik Huat | Officer | — | — | Stock Options (right to buy) | 40,000 | 7.00 | 280.0K | 0 | D | ↗ |
| 2026-04-30 | Teoh Pui Pui | Director / Officer / 10% Owner | A-Award | A | Class B Ordinary Shares | 750,000 | 0.00 | — | 816,520 | D | ↗ |
| 2026-04-30 | Siaw Tung Yeng | Director / Officer / 10% Owner | A-Award | A | Class A Ordinary Shares | 750,000 | 0.00 | — | 900,788 | D | ↗ |
| 2026-03-18 | Teoh Pui Pui | Director / Officer | — | — | Class B Ordinary Shares | 0 | 0.00 | — | 66,520 | D | ↗ |
| 2026-03-18 | Tan Kim Han Raymond | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Siaw Tung Yeng | Director / Officer | — | — | Class A Ordinary Shares | 0 | 0.00 | — | 150,788 | D | ↗ |
| 2026-03-18 | Rijpma Gabe Iede | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Leong Aik Huat | Officer | — | — | Class A Ordinary Shares | 0 | 0.00 | — | 45,468 | D | ↗ |
| 2026-03-18 | Ho Hin Yip | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aik Huat Leong | Chief Financial Officer | — | male |
| Chien Howh Chin | Financial Controller | — | male |
| Pui Pui Teoh | Co-Founder, Co-CEO, COO & Director | — | — |
| Seng Taat Siaw | Chief Medical Officer | — | — |
| Siew Siew Chan | Chief Technology Officer | — | female |
| Tung Yeng Siaw | Co-Founder, Co-CEO & Chairman of the Board | — | — |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MNDR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
